Regulatory concerns at various phases of drug development.
Aurecchia
S
S
Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, USA.
Orloff
D
D
Sobel
S
S
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000592:standards*; D015195:Drug Design; D004341:Drug Evaluation / Q000592:standards*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007880:Legislation, Drug / Q000592:standards*; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
D000960:Hypolipidemic Agents